COVID-19: Information for pharmacists
Our response to the pandemic is evolving rapidly. We will keep this page updated.
Last updated: 26 March 2020, 12:42pm
On this page:
- What happens if a medicine runs low
- Use Rule 4.4.2 at your discretion
- NPPA nominated pharmacy requirement removed
- PPE not funded by PHARMAC
- Who to contact
We know this is a difficult time for pharmacists. We appreciate your work. Kia kaha.
To support social distancing, we encourage pharmacists to use the Access Exemption Rule in the Schedule (4.4.2).
This allows pharmacists to dispense prescriptions all at once to certain types of patients, whether or not those products are on the stat list. We authorise pharmacists to also use this rule for people who:
- are immunocompromised
- are elderly
- have underlying health conditions.
We will post on our website and communicate with pharmacists when we need to take measures to restrict access to medicines.
We've removed the requirement to nominate a specific pharmacy while New Zealand is under Level 4 movement restrictions.
This allows people to contine to access their medication even if they can't get to their nominated pharmacy.
During the response to COVID-19:
- NPPA medication can be dispensed by any pharmacy
- approved lamotrigine exceptional circumstances medication can be dispensed by any pharmacy
- approved lamotrigine exceptional circumstances medication no longer need to be dispensed as a specified dose.
Sector Operations will process claims
Sector Operations have advised that they will be able to process claims that do not originate from the nominated pharmacy.
We will manage wastage on a case-by-case basis if the patient does not return to the nominated pharmacy.
PHARMAC does not fund PPE. The National Health Co-ordination Centre (NHCC) is coordinating the pandemic supply of these items with their supplier.
If you have questions, email us on email@example.com
We are experiencing a high number of enquiries, we recommend you email at this time.
Last updated: 27 March 2020